ALK and non-small cell lung carcinoma: For example, G1202R has been detected in biopsy specimens from patients with ALK-rearranged NSCLC who relapsed on brigatinib, suggesting that its potency may be compromised with this mutation; however, some cases were effective with brigatinib treatment.